EcoDrugPlus

Ensembl ID : ENSODEG00000020350
Gene Symbol: -
Cross references: -
382 Possible Orthologues:

Ensembl ID : ENSODEG00000014697
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSODEG00000015294
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSODEG00000006274
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSODEG00000007003
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSODEG00000007370
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSODEG00000012492
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSODEG00000019455
Gene Symbol: -
Cross references: -
142 Possible Orthologues:

Ensembl ID : ENSODEG00000007723
Gene Symbol: -
Cross references: -
99 Possible Orthologues:

Ensembl ID : ENSODEG00000000783
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSODEG00000020224
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSODEG00000012582
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).